proved that CCR7-modified anti-CD19 CAR-NK cells effectively controlled the growth of CD19-positive lymphoma in mouse models by enhancing the infiltration of CAR-NK cells towards chemokine ligands, CCL9 which produced by lymphoma cells (113). This evidence concerns the gene CD19 and lymphoma.